Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
Τheodoros Karampitsakos, Ουρανία Παπαϊωάννου, Panagiota Tsiri, Matthaios Katsaras, Andreas Katsimpris, Andreas P. Kalogeropoulos, Elli Malakounidou, Eirini Zarkadi, Georgios Tsirikos, Vasiliki V. Georgiopoulou, Vasilina Sotiropoulou, Electra Koulousousa, Charikleia Chourpiliadi, Apostolos Matsioulas, Maria Lagadinou, Fotios Sampsonas, Karolina Akinosoglou, Markos Marangos, Αrgyris Τzouvelekis
Topics & Concepts
TocilizumabMedicineMechanical ventilationRandomized controlled trialHazard ratioInternal medicineSurgeryConfidence intervalDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research